BRPI0812784A2 - Composição farmacêutica compreendendo um substrato e um revestimento contendo um ingrediente ativo e polivinilálcool - Google Patents

Composição farmacêutica compreendendo um substrato e um revestimento contendo um ingrediente ativo e polivinilálcool

Info

Publication number
BRPI0812784A2
BRPI0812784A2 BRPI0812784-0A2A BRPI0812784A BRPI0812784A2 BR PI0812784 A2 BRPI0812784 A2 BR PI0812784A2 BR PI0812784 A BRPI0812784 A BR PI0812784A BR PI0812784 A2 BRPI0812784 A2 BR PI0812784A2
Authority
BR
Brazil
Prior art keywords
substrate
pharmaceutical composition
active ingredient
polyvinyl alcohol
coating containing
Prior art date
Application number
BRPI0812784-0A2A
Other languages
English (en)
Inventor
Glenn E Fritz
Joseph P Reo
Mohammed A Kabir
Original Assignee
Schering Plough Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Healthcare filed Critical Schering Plough Healthcare
Publication of BRPI0812784A2 publication Critical patent/BRPI0812784A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0812784-0A2A 2007-06-01 2008-05-30 Composição farmacêutica compreendendo um substrato e um revestimento contendo um ingrediente ativo e polivinilálcool BRPI0812784A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94157707P 2007-06-01 2007-06-01
PCT/US2008/006914 WO2008150493A1 (en) 2007-06-01 2008-05-30 Pharmaceutical composition comprising a substrate and a coating containing an active ingredient and polyvinylalcohol

Publications (1)

Publication Number Publication Date
BRPI0812784A2 true BRPI0812784A2 (pt) 2014-12-02

Family

ID=39768532

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0812784-0A2A BRPI0812784A2 (pt) 2007-06-01 2008-05-30 Composição farmacêutica compreendendo um substrato e um revestimento contendo um ingrediente ativo e polivinilálcool

Country Status (8)

Country Link
US (1) US20080299186A1 (pt)
EP (1) EP2164472A1 (pt)
CN (1) CN101848706A (pt)
BR (1) BRPI0812784A2 (pt)
CA (1) CA2697959A1 (pt)
MX (1) MX2009013054A (pt)
RU (1) RU2009148862A (pt)
WO (1) WO2008150493A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2210595A1 (en) 2009-01-14 2010-07-28 LEK Pharmaceuticals d.d. Active coating of pharmaceutical dosage forms
EP2611442B1 (en) * 2010-09-03 2018-07-04 Bristol-Myers Squibb Company Drug formulations using water soluble antioxidants
CN104914096B (zh) * 2015-05-07 2018-02-16 西北农林科技大学 一种克伦特罗检测工作液及检测方法

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2993836A (en) * 1958-02-20 1961-07-25 Dow Chemical Co Sustained release tablets
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
US5025019A (en) * 1984-04-09 1991-06-18 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
US5085865A (en) * 1989-04-12 1992-02-04 Warner-Lambert Company Sustained release pharmaceutical preparations containing an analgesic and a decongestant
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
ATE118345T1 (de) * 1990-08-07 1995-03-15 Pfizer Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen.
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
US6160020A (en) * 1996-12-20 2000-12-12 Mcneill-Ppc, Inc. Alkali metal and alkaline-earth metal salts of acetaminophen
MX9701946A (es) * 1997-03-14 1998-04-30 Arturo Jimenez Bayardo Solucion oftalmica transportadora.
EP1021204B1 (en) * 1997-09-26 2005-12-28 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US6602521B1 (en) * 1998-09-29 2003-08-05 Impax Pharmaceuticals, Inc. Multiplex drug delivery system suitable for oral administration
US6521254B2 (en) * 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
US6267986B1 (en) * 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
US6114346A (en) * 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine
AU2276801A (en) * 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
WO2001045668A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
WO2001089476A1 (en) * 2000-05-19 2001-11-29 Npd Llc Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
WO2002036077A2 (en) * 2000-11-06 2002-05-10 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US20030236275A1 (en) * 2002-06-20 2003-12-25 Schering Corporation Treatment methods of nasal congestion and nasal obstruction
US7163696B2 (en) * 2001-10-11 2007-01-16 Pfizer Inc. Pharmaceutical formulations
US20030083354A1 (en) * 2001-10-26 2003-05-01 Pediamed Pharmaceuticals, Inc. Phenylephrine tannate and pyrilamine tannate salts in pharmaceutical compositions
US20030114535A1 (en) * 2001-12-14 2003-06-19 Jame Fine Chemicals, Inc. Dextrochlorpheniramine tannate
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US6979689B2 (en) * 2002-12-20 2005-12-27 Pediamed Pharmaceuticals, Inc. Compositions and methods for treating upper respiratory congestion
US20040214215A1 (en) * 2003-03-07 2004-10-28 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
US20050152967A1 (en) * 2003-03-28 2005-07-14 Pfab, Lp Dynamic variable release
US20050026890A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
US20050095288A1 (en) * 2003-11-03 2005-05-05 Andrx Labs, Llc Decongestant and expectorant tablets
US20050266032A1 (en) * 2003-12-17 2005-12-01 Sovereign Pharmaceuticals, Ltd. Dosage form containing multiple drugs
US9492541B2 (en) * 2004-09-14 2016-11-15 Sovereign Pharmaceuticals, Llc Phenylepherine containing dosage form
NZ555909A (en) * 2004-12-13 2009-11-27 Mcneil Ppc Inc Compositions and methods for reducing the degradation of phenylephrine by oxygen
US20070014855A1 (en) * 2005-07-12 2007-01-18 Rahul Gawande S Stable desloratadine compositions
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
US8940796B2 (en) * 2006-02-21 2015-01-27 Wyeth Llc Phenylephrine liquid formulations
WO2007143158A2 (en) * 2006-06-01 2007-12-13 Schering-Plough Healthcare Products, Inc. Sustained release pharmaceutical formulation comprising phenylephrine
US20080014274A1 (en) * 2006-07-14 2008-01-17 Wyeth Enhanced stability phenylephrine liquid compositions
US9005652B2 (en) * 2006-07-25 2015-04-14 Wyeth Chewable tablet containing phenylephrine
US7378082B1 (en) * 2007-11-05 2008-05-27 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects

Also Published As

Publication number Publication date
RU2009148862A (ru) 2011-07-20
US20080299186A1 (en) 2008-12-04
CA2697959A1 (en) 2008-12-11
EP2164472A1 (en) 2010-03-24
MX2009013054A (es) 2010-01-15
WO2008150493A1 (en) 2008-12-11
CN101848706A (zh) 2010-09-29

Similar Documents

Publication Publication Date Title
DK2692341T3 (da) Misbrugs-resistent lægemiddelformulering
BRPI0810696A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0919942A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0907562A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0921375A2 (pt) composto, composição farmacêutica, e, uso de um composto
PL2034970T3 (pl) Preparat farmaceutyczny o przedłużonym uwalnianiu zawierający fenylefrynę
DK2099406T3 (da) Opbevarings- og udleveringsindretninger til administration af oralt transmucosale doseringsformer
BRPI0915411A2 (pt) partículas revestidas contendo agentes farmaceuticamente ativos
BRPI0716171A2 (pt) composto, composiÇço farmacÊutica e uso de um composto.
EP2025337A4 (en) TOPICAL PHARMACEUTICAL COMPOSITION
BRPI0807078A2 (pt) Composto, e, formulação farmacêutica
DK2346495T4 (da) Farmaceutisk formulering 514
BRPI0815709A2 (pt) composro, composição farmacêutica, e, uso de um composto.
JP2008539179A5 (ja) 殺虫活性物質併用の組み合わせ
BRPI0821115A2 (pt) Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
BRPI0921879A2 (pt) composto, composição farmacêutica , e, uso de um composto
BRPI0810161A2 (pt) Composto, preparação farmacêutica, composição farmacêutica, e, uso de um composto
EP2005958A4 (en) TOPICAL PHARMACEUTICAL COMPOSITION
BRPI0716698A2 (pt) Composto, composição farmacêutica e uso de um composto
BRPI0917693A2 (pt) composto derivado de triazol, composição farmacêutica, e, uso de um derivado de triazol
BRPI0812990A2 (pt) Dispositivo de acondicionamento e de administração sublingual de princípios ativos
BRPI0812942A2 (pt) Composto, composição farmacêutica e uso de um composto
BRPI0810019A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0906937A2 (pt) composto, composição farmacêutica, e, uso de um composto
EP2266626A4 (en) COMPOSITION FOR TOPICAL APPLICATION WITH A TRANSCRIPTION FACTOR DECOY AS AN ACTIVE SUBSTANCE

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: MSD CONSUMER CARE, INC. (US)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.